President Trump made more than $2 billion last year — far exceeding his presidential salary of $400,000. His growing fortunes are raising questions about his allegiance to investors, particularly foreign ones, as he makes policy decisions and shapes the direction of the country.

The contributing Opinion writer Christopher Caldwell and the Harvard law professor Jack Goldsmith discuss how the president has amassed this fortune, whether it’s legal and if the United States is becoming a kleptocracy.

Note: As we work on relaunching 'Interesting Times,' the show will feature a series of guest hosts in the coming months.

00:00 Why Trump’s Wealth Is Unusual
01:30 Presidential Ethics Before Trump
02:28 Trump’s Crypto and Foreign Money Flows
06:12 Is It a Kleptocracy?
07:36 What’s Unconstitutional About Trump’s Finances
10:43 The U.A.E. and Trump’s Foreign Policy
13:41 How Trump’s Weaponization Is Changing Government
16:42 What Congress Could Do
18:59 The Tit for Tat Weaponization
24:13 Can Trump Pardon Himself?
26:57 The “Deep-State” Crackdown
36:59 Oversight Norms and Voter Verdict
42:46 Closing Thoughts

(A full transcript of this episode is available on the Times website.)

Thoughts? Email us at [email protected]. Please subscribe to our YouTube Channel, Interesting Times.

 

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“Interesting Times” is on a brief hiatus. Before we return next month, we’re bringing you an interview from “The Ezra Klein Show” with Ross Douthat about his 17 years as a conservative columnist at The New York Times. But Ross and Ezra go back even further, to the nascent days of political blogging. They talk about the seismic changes they’ve witnessed in the media industry over the years and the art of changing minds.

(A full transcript of this episode is available on the Times website here.)

Thoughts? Email us at [email protected]. Please subscribe to our YouTube Channel, Interesting Times.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

For my final episode as host of “Interesting Times,” I wanted a fitting finale — a conversation that encapsulates the ambition of this show: examining how seemingly radical ideas are steadily entering the mainstream of American politics, technology and culture. Few ideas are as radical as the hope of significant life extension and the quest to live forever.

My guest today thinks he can outrun death. After selling his tech company for hundreds of millions of dollars and experiencing a profound religious crisis, Bryan Johnson turned his own body into the ultimate science project, centered on an explicit mission: Don’t die.

But why does Johnson want to live forever, and what lessons can his algorithmically driven lifestyle bring to the rest of us?

It’s been an honor hosting this podcast and navigating these strange waters with you. “Interesting Times” will be back with new episodes and new hosts in the fall.

0:00 Why Bryan Johnson Wants to Defeat Death 1:18 The Core Premise of "Don't Die" vs. Immortality 3:26 Selling Braintree/Venmo & Personal Collapse 6:33 Leaving the Mormon Church & Searching for Meaning 7:45 Launching Project Blueprint: Body as Philosophy 11:35 Bryan Johnson’s Daily Longevity Routine & Biological Age Metrics 15:06 How AI Builds "Autonomous Health" for the Human Body 17:58 The Best Habits to Optimize Health: Sleep & Heart Rate 21:32 Blueprint Products, Supplements, & Testing 23:46 Reversing Biological Aging: Saunas & HBOT 25:24 Can Psychedelics Extend Lifespan? Psilocybin Longevity Trials 31:07 How Falling in Love Has Changed His Perspective 34:06 Diagnosed with an Incurable Autoimmune Disease 35:51 The Risk of Gerontocracy 53:53 Can Humanity Defeat Death? Societal & Philosophical Impacts

(A full transcript of this episode is available on the Times website.)

Thoughts? Email us at [email protected]. Please subscribe to our YouTube Channel, Interesting Times with Ross Douthat.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There’s a saying that comes to mind these days: May you live in interesting times. It’s understood to be a curse, even though it sounds like a blessing.

“Interesting Times With Ross Douthat” is a new weekly podcast from New York Times Opinion. Every Thursday, he will map the new world order through interviews and conversations. Answering questions like: What does our new political era really look like? What is the future of democracy around the world, with American empire in retreat? What happens to movies and books — all of culture — in our digital and A.I.-dominated age?

Thoughts? Email us at [email protected].

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.